🇺🇸 FDA
Patent

US 7323334

Screening and therapeutic methods relating to neurogenesis

granted A61PA61P21/04A61P25/00

Quick answer

US patent 7323334 (Screening and therapeutic methods relating to neurogenesis) held by The Regents of the University of California expires Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61P, A61P21/04, A61P25/00, A61P25/02, A61P25/14